메뉴 건너뛰기




Volumn 15, Issue 7, 2009, Pages 890-891

Defining Conditioning Regimens for BMT-Recognition of "Regimens of Intermediate Intensity"

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CARMUSTINE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; THYMOCYTE ANTIBODY;

EID: 67349133132     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.02.012     Document Type: Letter
Times cited : (2)

References (4)
  • 1
    • 59349093509 scopus 로고    scopus 로고
    • Reduced intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Centre for International Blood and Marrow Transplant Research
    • Giralt S., Ballen K., Rizzo D., et al. Reduced intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Centre for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 15 (2009) 367-469
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 367-469
    • Giralt, S.1    Ballen, K.2    Rizzo, D.3
  • 2
    • 9144239822 scopus 로고    scopus 로고
    • BEAM-Alemtuzumab reduced intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD toxicity and survival in 65 patients
    • Faulkner R., Craddock C., Byrne J.L., et al. BEAM-Alemtuzumab reduced intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD toxicity and survival in 65 patients. Blood 103 (2004) 428-434
    • (2004) Blood , vol.103 , pp. 428-434
    • Faulkner, R.1    Craddock, C.2    Byrne, J.L.3
  • 3
    • 38649089434 scopus 로고    scopus 로고
    • Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the Europen Group for Blood and Marrow Transplantation
    • Sureda A., Robinson S., Canals C., et al. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the Europen Group for Blood and Marrow Transplantation. J Clin Oncol 26 (2008) 455-462
    • (2008) J Clin Oncol , vol.26 , pp. 455-462
    • Sureda, A.1    Robinson, S.2    Canals, C.3
  • 4
    • 47649090155 scopus 로고    scopus 로고
    • Reduced toxicity conditioning with Fludarabine BCNU and Melphalan in allogeneic haemopoietic cell transplantation: particular activity against advanced haematologic malignancies
    • Marks R., Potthof K., Hahn J., et al. Reduced toxicity conditioning with Fludarabine BCNU and Melphalan in allogeneic haemopoietic cell transplantation: particular activity against advanced haematologic malignancies. Blood 112 (2008) 415-424
    • (2008) Blood , vol.112 , pp. 415-424
    • Marks, R.1    Potthof, K.2    Hahn, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.